Fuchs, Christian
Scheer, Christian S.
Wauschkuhn, Steffi
Vollmer, Marcus
Meissner, Konrad
Hahnenkamp, Klaus
Gründling, Matthias
Selleng, Sixten
Thiele, Thomas
Borgstedt, Rainer
Kuhn, Sven-Olaf
Rehberg, Sebastian
Scholz, Sean Selim
Funding for this research was provided by:
Universität Bielefeld
Article History
Received: 25 August 2023
Accepted: 28 March 2024
First Online: 17 April 2024
Declarations
:
: The present single centre study was conducted as a secondary analysis of a prospective observational trial that was performed to evaluate the long-term effects of a local continuous sepsis training program [CitationRef removed]. The study was performed according to the German data protection rules. The local ethics committee (Ethikkomission an der Universitätsmedizin Greifswald) approved the study and granted a waiver of informed consent.
: Not applicable.
: M.G.: The author declares that he received honoraria for lectures and research grants from bioMérieux Deutschland, Becton Dickinson GmbH, Accelerate Diagnostics, Curetis GmbH, and MSD Sharp & Dohme GmbH, outside the submitted work.T.T.: The author reports personal fees from Bristol Myers Squibb and personal fees from Bayer, Daichii Sankyo, Pfizer, Novo Nordisk and Novartis, outside the submitted work.S.R.: The author is a medical advisor for Fresenius Kabi Germany and received honoraria and travel expenses from Amomed Pharma and CSL Behring, outside the submitted work.S.S.S.: The author declares that he received honoraria for lectures from Pfizer, outside the submitted work.C.F., C.S., S.W., M.V., K.M., K.H., S.S., R.B. and S.-O.K. declare no competing interests.